Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney

American Journal of Physiology - Renal Physiology

Volumn 277, Issue 6 46-6, 1999, Pages

  Yang, Tianxin ^a   Michele, Daniel E ^a   Park, John ^a   Smart, Ann M ^a   Lin, Zhiwu ^a   Brosius III, Frank C ^a   Schnermann, Jurgen B ^a   Briggs, Josephine P ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

15 deoxy 12,14 prostaglandin J2; Acyl coenzyme A synthase; Microdissected nephron segments; Reverse transcription polymerase chain reaction

Indexed keywords

LONG CHAIN FATTY ACID COENZYME A LIGASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; ENERGY METABOLISM; KIDNEY COLLECTING TUBULE; KIDNEY DEVELOPMENT; KIDNEY MEDULLA; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0033387870     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.277.6.f966     Document Type: Article

References (36)

1. Altiok, S., M. Xu, and B. M. Spiegelman. PPARγ induces cell cycle withdraw: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11: 1987-1998, 1997.
2. Berger, J., P. Bailey, C. Biswas, C. A. Cullinan, T. W. Doebber, N. S. Hayes, R. Saperstein, R. G. Smith, and M. D. Leibowitz. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137: 4189-4190, 1996.
3. Braissant, O., F. Foufelle, C. Scotto, M. Dauca, and W. Wahli. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in adult rat. Endocrinology 137: 354-366, 1996.
4. Devchand, P. R., H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli. The PPARa-leukotriene B4 pathway to inflammation control. Nature 384: 39-43, 1996.
5. Dreyer, C., G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli. Control of peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68: 879-887, 1992.
6. Dunn, M. J., and V. L. Hood. Prostaglandins and the kidney. Am. J. Physiol. 233 (Renal Fluid Electrolyte Physiol. 2): F169-F184, 1977.
7. Dunn, M. J., R. S. Staley, and M. Harrison. Characterization of prostaglandin production in tissue culture of rat renal medullary cells. Prostaglandins 12: 37-49, 1976.
8. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83: 803-812, 1995.
9. 2 and related compounds: an update. Prostaglandins Leukot. Essent. Fatty Acids 47: 1-12, 1992.
10. Gearing, K. L., M. Gottlicher, M. Teboul, E. Widmark, and J. A. Gustafsson. Interaction of the peroxisome proliferator activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 90: 1440-1444, 1993.
11. Goettlicher, M., E. Widmark, Q. Li, and J. A. Gustafsson. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 89: 4653-4657, 1992.
12. Guan, Y., Y. Zhang, L. Davis, and M. D. Breyer. Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am. J. Physiol. 273 (Renal Physiol. 42): F1013-F1022, 1997.
13. 2 in human urine. J. Biol. Chem. 32: 16619-16625, 1988.
14. Issemann, I., and S. Green. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferator. Nature 347: 645-650, 1990.
15. Keller, H., and W. Wahli. Peroxisome proliferator-activated receptors. Trends Endocrinol. Metab. 4: 291-296, 1993.
16. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83: 813-819, 1995.
17. Kliewer, S. A., B. M. Forman, B. Blumberg, S. E. Ong, U. Borgmeyer, D. J. Mangelsdorf, K. Umesono, and R. M. Evans. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 1: 7355-7359, 1994.
18. Koh, G. Y., D. R. Nussenzveig, J. Okolicany, D. A. Price, and T. Maack. Dynamics of atrial natriuretic factor-guanylate cyclase receptors and receptor ligand complexes in glomerular mesangial cells and renomedullary interstitial cells. J. Biol. Chem. 267: 11987-11994, 1992.
19. Krey, G., H. Keller, A. Mahfoudi, J. Medin, K. Ozato, C. Dreyer, and W. Wahli. Xenopus peroxisome proliferator activated receptors: genetic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids. J. Steroid Biochem. Mol. Biol. 47: 65-73, 1993.
20. Mandrup, S., and M. D. Lane. Regulating adipogenesis. J. Biol. Chem. 272: 5367-5370, 1997.
21. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. Evans. The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995.
22. Morikang, E., S. C. Benson, T. W. Kurtz, and H. A. Pershadsingh. Effects of thiazolidinediones on growth and differentiation of human aorta and coronary myocytes. Am. J. Hypertens. 10: 440-446, 1997.
23. Mukherjee, R., L. Jow, G. E. Croston, and J. R. Paterniti, ' Jr. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272: 8071-8076, 1997.
24. Narumiya, S., and M. Fukushima. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J. Pharmacol. Exp. Ther. 239: 500-505, 1986.
25. Narumiya, S., K. Ohno, and M. Fujiwara. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of cyclopentenone prostaglandins to nuclei. J. Pharmacol. Exp. Ther. 239: 506-511, 1986.
26. Reddy, J. K, M. S. Rao, D. E. Moody, and S. A. Qureshi. Peroxisome development in the regenerating pars recta (P3 segment) of the proximal tubules of the rat kidney. J. Histochem. Cytochem. 24: 1239-1248, 1976.
27. Schoonjians, K., B. Staels, and J. Auwerx. The peroxisome proliferator activated receptor (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302: 93-109, 1996.
28. Schoonjans, K., B. Staels, P. Grimaldi, and J. Auwerx. Acyl-CoA synthetase mRNA expression is controlled by fibricacid derivatives, feeding and liver proliferation. Eur. J. Biochem. 216: 615-622, 1993.
29. Suzuki, H., Y. Kawarabayasi, J. Kondo, T. Abe, K. Nishikawa, S. Kimura, T. Hashimoto, and T. Yamamoto. Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 265: 8681-8685, 1990.
30. Todd-Turla, K. M., E. Rusvai, A. Naray-Fejes-Toth, and G. Fejes-Toth. CFTR expression in cortical collecting duct cells. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39): F237-F244, 1996.
31. Tontonoz, P., E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8: 1224-1234, 1994.
32. Vandorpe, D. H., F. Ciampolillo, R. B. Green, and B. A. Stanton. Cyclic nucleotide-gated cation channels mediate sodium absorption by IMCD (mIMCD-K2) cells. Am. J. Physiol. 272 (Cell Physiol. 41): C901-C910, 1997.
33. Xing, G., L. Zhang, L. Zhang, T. Hernen, T. Yoshikawa, M. Smith, S. Weiss, and S. Detera-Wadleigh. Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem. Biophys. Res. Commun, 217: 1015-1025, 1995.
34. Yanase, T., T. Yashiro, K. Takitani, S. Kato, S. Taniguchi, R. Takayanagi, and H. Nawata. Differential expression of PPARγ1 and γ2 isoforms hi human adipose tissue. Biochem. Biophys. Res. Commun. 233: 320-324, 1997.
35. Yang, T., Y. G. Huang, I. Singh, J. Schnennann, and J. P. Briggs. Localization of bumetanide- and thiazide-sensitive Na-K-Cl cotransporters along the rat nephron. Am. J. Physiol. 271 (Renal Fluid Electrolyte Physiol. 40): F931-F939, 1996.
36. Yu, V. C., C. Delsert, B. Andersen, J. M. Holloway, O. V. Devary, A. M. Naar, S. Y. Kim, J. M. Boutin, C. K. Glass, and M. G. Rosenfeld. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67: 1251-1266, 1991.